Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E F Smit

Showing results (11-20 of 185) with videos related to

Pageof 19
Sort By:
Nederlands Tijdschrift Voor Geneeskunde|July 23, 1994
[Bacteremia caused by Streptococcus salivarius and S. Milleri, and colonic carcinoma]E F Smit, L Wijnja, W L Manson
Seminars in Oncology|September 5, 1998
Evaluation of new drugs in small cell lung cancer: the activity of gemcitabineP E Postmus, F M Schramel, E F Smit
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Phase II study of high-dose epirubicin and etoposide in advanced non-small cell lung cancerE F Smit, D A Piers, P E Postmus
Seminars in Oncology|April 1, 1992
A phase I study of daily oral teniposide for 20 daysE F Smit, T A Splinter, T C Kok
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1990
Etoposide and mesotheliomaE F Smit, H H Berendsen, P E Postmus
Chest|March 1, 1989
Oral etoposide for a 95-year-old patient with small cell lung cancerE F Smit, D T Sleijfer, P E Postmus
Cancer Treatment Reviews|August 17, 1999
Second-line chemotherapy and its evaluation in small cell lung cancerC Huisman, P E Postmus, G Giaccone, et al.
Respiration; International Review of Thoracic Diseases|June 9, 2005
Molecular pathology of non-small-cell lung cancerR H J Breuer, P E Postmus, E F Smit
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 31, 2000
Second-line chemotherapy in relapsing or refractory non-small-cell lung cancer: a reviewC Huisman, E F Smit, G Giaccone, et al.
Nederlands Tijdschrift Voor Geneeskunde|September 30, 2004
[Chemotherapy for metastased non-small cell lung cancer]H J M Groen, E F Smit, D Th Sleijfer
Pageof 19

Showing results (11-20 of 185) with videos related to

Sort By:
Pageof 19
Nederlands Tijdschrift Voor Geneeskunde|July 23, 1994
[Bacteremia caused by Streptococcus salivarius and S. Milleri, and colonic carcinoma]E F Smit, L Wijnja, W L Manson
Seminars in Oncology|September 5, 1998
Evaluation of new drugs in small cell lung cancer: the activity of gemcitabineP E Postmus, F M Schramel, E F Smit
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Phase II study of high-dose epirubicin and etoposide in advanced non-small cell lung cancerE F Smit, D A Piers, P E Postmus
Seminars in Oncology|April 1, 1992
A phase I study of daily oral teniposide for 20 daysE F Smit, T A Splinter, T C Kok
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1990
Etoposide and mesotheliomaE F Smit, H H Berendsen, P E Postmus
Chest|March 1, 1989
Oral etoposide for a 95-year-old patient with small cell lung cancerE F Smit, D T Sleijfer, P E Postmus
Cancer Treatment Reviews|August 17, 1999
Second-line chemotherapy and its evaluation in small cell lung cancerC Huisman, P E Postmus, G Giaccone, et al.
Respiration; International Review of Thoracic Diseases|June 9, 2005
Molecular pathology of non-small-cell lung cancerR H J Breuer, P E Postmus, E F Smit
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 31, 2000
Second-line chemotherapy in relapsing or refractory non-small-cell lung cancer: a reviewC Huisman, E F Smit, G Giaccone, et al.
Nederlands Tijdschrift Voor Geneeskunde|September 30, 2004
[Chemotherapy for metastased non-small cell lung cancer]H J M Groen, E F Smit, D Th Sleijfer
Pageof 19